Breathe easier knowing that your cows have received protection*
Discover the BOVILIS® respiratory vaccine portfolio featuring options allowing for cattle vaccination as early as one week of age.
Bovine respiratory disease (BRD) is the principal source of economic loss for the North American beef industry and a significant health problem for the dairy industry.1
Vaccinating cattle against common viral and bacterial respiratory pathogens helps to reduce the incidence of infectious disease, promote animal welfare and decrease the need for the use of antibiotics, which, in turn, reduces the risk of antimicrobial resistance.
The Merck Animal Health BOVILIS® line of respiratory vaccines include coverage against several viral and/or bacterial respiratory pathogens, providing veterinarians and producers with flexible options for customized vaccination programs in response to specific needs and disease risks*.
*Always read and follow label instructions to ensure the selected product is suitable for the animal to be vaccinated. Vaccination may not protect every animal that gets vaccinated.
Bovilis® Respiratory Vaccine
Mixing Instructions for 50-dose bottles†
Watch this video to learn how to prepare the 50-dose bottles of our Vista® vaccine before administration and download the guide for a handy reference.
†These mixing instructions apply to all vaccines listed on this page.
Bovilis® Nasalgen® 3-PMH
The only intranasal vaccine that helps provide 5-IN-1 protection against BRD. Helps provide broad respiratory protection against five of the most common viral and bacterial causes of BRD* in just ONE convenient dose.
- Minimum age: 1 week
- Dosage: 2 mL
- Administration: Intranasal
*Infectious bovine rhinotracheitis virus (IBR), bovine respiratory syncytial virus (BRSV), parainfluenza 3 virus (PI3), Mannheimia haemolytica and Pasteurella multocida
Bovilis® Vista® BVD CFP
The only standalone subcutaneous BVD vaccine. Helps protect against respiratory disease and fetal infection, including persistently infected calves, due to bovine virus diarrhea (BVD) virus Types 1 & 2.
- Minimum age: 3 months
- Dosage: 2 mL
- Administration: Subcutaneous
Vista® 5 SQ
Single-dose, 5-way modified-live vaccine for lasting protection against respiratory pathogens and reproductive diseases.
- Minimum age: 3 months
- Dosage: 2 mL
- Administration: Subcutaneous
Vista® 5 VL5 SQ
Single-dose, 5-way modified-live vaccine combined with inactivated cultures of Campylobacter and Leptospira.
- Minimum age: 6 months
- Dosage: 2 mL
- Administration: Subcutaneous
Vista® Once SQ
The only avirulent-live culture of Mannheimia haemolytica and Pasteurella multocida combined with a 5-way modified-live vaccine.
- Minimum age: 3 months
- Dosage: 2 mL
- Administration: Subcutaneous
Once PMH® SQ
On-label duration of immunity of at least 16 weeks against two leading bacterial causes of BRD: M. haemolytica and P. multocida.
- Minimum age: 3 months
- Dosage: 2 mL
- Administration: Subcutaneous
Once PMH® IN
The first intranasal vaccine to deliver a dose of both P. multocida and M. haemolytica antigens, for dual bacterial pneumonia protection.
- Minimum age: 1 week
- Dosage: 2 x 1 mL or 1 x 2 mL
- Administration: Intranasal
1. Hodgins DC, Conlon JA, and Shewen PE. Respiratory viruses and bacteria in cattle. Polymicrobial Diseases. NCBI Bookshelf A service of the National Library of Medicine, National Institutes of Health, Washington (DC): ASM Press (2002). Available at https://www.ncbi.nlm.nih.gov/books/NBK2480/?report=printable (Accessed in November 2020)
BOVILIS® and VISTA® are registered trademarks of Intervet International B.V.; NASALGEN® and ONCE PMH® are registered trademark of Intervet Inc. All trademarks used under license.